Humira (adalimumab)

Humira (adalimumab) is a medication that reduces inflammation in the body by blocking a specific protein called TNF-alpha, which plays a major role in autoimmune diseases. It is mainly used to treat conditions like rheumatoid arthritis, psoriasis, and Crohn's disease. By inhibiting this protein, Humira helps alleviate symptoms, improve quality of life, and prevent further damage caused by these diseases. It is typically administered as an injection and requires a prescription from a healthcare provider. Regular monitoring is necessary to manage potential side effects and assess treatment effectiveness.